-
Type
All -
Tags
All -
Strategic pillar
All -
Beamlines
All -
From Year
2022 -
To Year
2023 -
Quarter
All- All
- 2026 - Q4
- 2026 - Q3
- 2026 - Q2
- 2026 - Q1
- 2025 - Q4
- 2025 - Q3
- 2025 - Q2
- 2025 - Q1
- 2024 - Q4
- 2024 - Q3
- 2024 - Q2
- 2024 - Q1
- 2023 - Q4
- 2023 - Q3
- 2023 - Q2
- 2023 - Q1
- 2022 - Q4
- 2022 - Q3
- 2022 - Q2
- 2022 - Q1
- 2021 - Q4
- 2021 - Q3
- 2021 - Q2
- 2021 - Q1
- 2020 - Q4
- 2020 - Q3
- 2020 - Q2
- 2020 - Q1
- 2019 - Q4
- 2019 - Q3
- 2019 - Q2
- 2019 - Q1
- 2018 - Q4
- 2018 - Q3
- 2018 - Q2
- 2018 - Q1
- 2017 - Q4
- 2017 - Q3
- 2017 - Q2
- 2017 - Q1
- 2016 - Q4
- 2016 - Q3
- 2016 - Q2
- 2016 - Q1
- 2015 - Q4
- 2015 - Q3
- 2015 - Q2
- 2015 - Q1
- 2014 - Q4
- 2014 - Q3
- 2014 - Q2
- 2014 - Q1
- 2013 - Q4
- 2013 - Q3
- 2013 - Q2
- 2013 - Q1
- 2012 - Q4
- 2012 - Q3
- 2012 - Q2
- 2012 - Q1
- 2011 - Q4
- 2011 - Q3
- 2011 - Q2
- 2011 - Q1
- 2010 - Q4
- 2010 - Q3
- 2010 - Q2
- 2010 - Q1
- 2009 - Q4
- 2009 - Q3
- 2009 - Q2
- 2009 - Q1
- 2008 - Q4
- 2008 - Q3
- 2008 - Q2
- 2008 - Q1
- 2007 - Q4
- 2007 - Q3
- 2007 - Q2
- 2007 - Q1
- 2006 - Q4
- 2006 - Q3
- 2006 - Q2
- 2006 - Q1
- 2005 - Q4
- 2005 - Q3
- 2005 - Q2
- 2005 - Q1
- 2004 - Q4
- 2004 - Q3
- 2004 - Q2
- 2004 - Q1
- 2003 - Q4
- 2003 - Q3
- 2003 - Q2
- 2003 - Q1
- 2002 - Q4
- 2002 - Q3
- 2002 - Q2
- 2002 - Q1
- 2001 - Q4
- 2001 - Q3
- 2001 - Q2
- 2001 - Q1
| Publication | Beamlines | Type | Strategic Pillar |
|---|---|---|---|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. | Patent | ||
| (2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0. | Patent | ||
| (2023). Antibodies to tigit. Patent Number: IL298111A. | Patent | ||
| (2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2. | Patent | ||
| (2023). teclistamab. Patent Number: NL301219I2. | Patent | ||
| (2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1. | Patent | ||
| (2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T. | Patent | ||
| (2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2. | Patent | ||
| (2022). ANTIBODY EPITOPE. Patent Number: PT3311171T. | Patent | ||
| (2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T. | Patent | ||
| 수아레즈 조안 세오아네; 폴게이라 주딧 아니도; 조 프란슨; 진-필리프 줄리엔; 스웨타 라만 et al. (2023). Antibodies to LIF and their uses. Patent Number: KR102599557B1. | CMCF-ID | Patent | Health |
| 제임스 필립 오코넬; 존 로버트 포터; 알라스테어 로손; 다니엘 존 라이트우드; 레베카 제인 우튼 et al. (2023). antibody. Patent Number: KR102599907B1. | Patent | ||
| 켈시 시빅 고티에; 니겔 펠험 클린턴 워커; 샤오닝 자오; 존 리핀코트 (2023). Antibodies to TIGIT. Patent Number: KR20230019152A. | Patent | ||
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2022). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR20220031728A. | Patent | ||
| 한 리; 도로씨아 코미노스; 지에 장; 알라 프리츠커; 매튜 데이비슨 et al. (2022). Antibodies to bradykinin b1 receptor ligands. Patent Number: KR102367723B1. | Patent |